Evidence map›Paper›PMID 36983627›Full record

ArticleJournal of personalized medicine2023

Are Semiquantitative Methods Superior to Deauville Scoring in the Monitoring Therapy Response for Pediatric Hodgkin Lymphoma?

Firuz Ibrahim, Michela Gabelloni, Lorenzo Faggioni, Subramanyam Padma, Arun R Visakh, Dania Cioni, Emanuele Neri

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of personalized medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Firuz IbrahimDepartment of Nuclear Medicine and PET-CT, Burjeel Medical City, Abu Dhabi 92510, United Arab Emirates.
Michela GabelloniAcademic Radiology, Department of Translational Research, University of Pisa, 56126 Pisa, Italy.
Lorenzo FaggioniAcademic Radiology, Department of Translational Research, University of Pisa, 56126 Pisa, Italy.ORCID 0000-0001-5262-4489
Subramanyam PadmaAmrita Institute of Medical Sciences, Kochi 682041, Kerala, India.
Arun R VisakhDepartment of Nuclear Medicine, VPS Lakeshore Hospital, Kochi 682040, Kerala, India.
Dania CioniAcademic Radiology, Department of Translational Research, University of Pisa, 56126 Pisa, Italy.ORCID 0000-0002-5120-886X
Emanuele NeriAcademic Radiology, Department of Translational Research, University of Pisa, 56126 Pisa, Italy.ORCID 0000-0001-7950-4559
University of Pisa · ITAmrita Institute of Medical Sciences and Research Centre · INLakeshore Hospital · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tailoring treatment in patients with Hodgkin lymphoma (HL) is paramount to maximize outcomes while avoiding unnecessary toxicity. We aimed to compare the performance of SUV

Indexed as

[18F]fluoro-2-deoxy-2-D-glucose (18F-FDG)chemotherapyDeauville scoreHodgkin lymphomaPET ratio (rPET)positron emission tomography computed tomography (PET-CT)response predictionstandardized uptake value (SUV)

Identifiers

PMID36983627
PMCPMC10055884
OpenAlexW4322741599

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.